
camp elisa hama antibodies hmgb1 elisa Isotype ldh assay kit mobp antibody Monoclonal Pcr pge2 elisa plc gamma 2 protein carbonyl assay protein carbonyls tbars assay kit tdgf1 triglyceride assay upp1 Vector
Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer’s disease models
Richard
- 0
At current, therapies for Alzheimer’s illness can briefly relieve signs however can’t stop the decline of cognitive means and different neurodegenerative modifications. Dendrobium nobile Lindl alkaloid is the principle lively element of Dendrobium nobile Lindl.
Dendrobium nobile Lindl alkaloid has been proven to withstand getting old, lengthen life span, and exhibit immunomodulatory results in animals. This evaluate summarizes the mechanisms behind the neuroprotective results reported in Alzheimer’s illness animal fashions. The neuroprotective results of Dendrobium nobile Lindl alkaloid haven’t been studied in sufferers.
The mechanisms by which Dendrobium nobile Lindl alkaloid has been reported to enhance cognitive dysfunction in Alzheimer’s illness animal fashions could also be related to extracellular amyloid plaque manufacturing, regulation of tau protein hyperphosphorylation, inhibition of neuroinflammation and neuronal apoptosis, activation of autophagy, and enhanced synaptic connections.
Uncommon manifestation of ocular immune reconstitution inflammatory syndrome from mycobacterium scrofulaceum an infection in a affected person with AIDS
Immune reconstitution inflammatory syndrome (IRIS) is a standard complication following the initiation of antiretroviral remedy (ART). Essentially the most generally related pathogens embody Mycobacterium tuberculosis and Cryptococcus spp.[1] IRIS following nontuberculosis mycobacteria (NTM) an infection is rare, significantly, IRIS following NTM conjunctivitis.
Herein, we current a case of Mycobacterium scrofulaceum conjunctivitis with peripheral ulcerative keratitis and orbital cellulitis in a 45-year-old affected person with AIDS who developed IRIS 1 month after beginning ART remedy. A mixture of each systemic and topical antibiotics along with corticosteroids had been used and resulted in a passable final result with no early recurrence.
This case demonstrated a uncommon ocular IRIS manifestation involving each the exterior eye and orbit and to the creator’s data is the primary case within the literature by which M. scrofulaceum has been discovered to be concerned within the eye.
Glial TDP-43 and TDP-43 induced glial pathology, give attention to neurodegenerative proteinopathy syndromes
Since its discovery in 2006, TAR DNA binding protein 43 (TDP-43) has pushed quickly evolving analysis in neurodegenerative ailments together with amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), and limbic predominant age-related TDP-43 encephalopathy (LATE). TDP-43 mislocalization or aggregation is the hallmark of TDP-43 proteinopathy and is related to cognitive impairment that may be mapped to its regional deposition.
Research in human tissue and mannequin programs exhibit that TDP-43 might potentiate different proteinopathies such because the amyloid or tau pathology seen in Alzheimer’s Illness (AD) within the mixture of AD+LATE. Regardless of this rising physique of literature, there stay gaps in our understanding of whether or not there may be heterogeneity in TDP-43 pushed mechanisms throughout cell varieties.
The rising observations of correlation between TDP-43 proteinopathy and glial pathology recommend a relationship between the 2, together with pathogenic glial cell-autonomous dysfunction and dysregulated glial immune responses to neuronal TDP-43.
On this evaluate, we focus on the out there information on TDP-43 in glia inside the context of the neurodegenerative ailments ALS and FTLD and spotlight the present lack of understanding about glial TDP-43 interplay in AD+LATE. TDP-43 has confirmed to be a major modulator of cognitive and neuropathological outcomes. A deeper understanding of its position in numerous cell varieties might present related insights into neurodegenerative syndromes.
Affiliation of Rosacea With Cardiovascular Illness: A Retrospective Cohort Research
Background There’s rising proof that rosacea, a continual cutaneous inflammatory illness, is related to numerous systemic ailments. Nevertheless, its affiliation with heart problems (CVD) stays controversial. We aimed to analyze whether or not sufferers with rosacea are at elevated danger of growing CVD.
Strategies and Outcomes This retrospective cohort research from the Korean Nationwide Well being Insurance coverage Service-Well being Screening Cohort included sufferers with newly recognized rosacea (n=2681) and age-, sex-, and index year-matched reference populations with out rosacea (n=26 810) between 2003 and 2014. The first final result was subsequent CVD together with coronary coronary heart illness and stroke.
Multivariable Cox regression analyses had been used to judge adjusted hazard ratios for subsequent CVD adjusted for main danger elements of CVD. In contrast with the reference inhabitants (13 410 girls; imply [SD] age, 57.7 [9.2] years), sufferers with rosacea (1341 girls; imply [SD] age, 57.7 [9.2] years) displayed an elevated danger for CVD (adjusted hazard ratios, 1.20; 95% CI, 1.03-1.40) and coronary coronary heart illness (adjusted hazard ratios, 1.29; 95% CI, 1.05-1.60).
The chance for stroke was not considerably elevated (adjusted hazard ratios, 1.12; 95% CI, 0.91-1.37). Conclusions This research means that sufferers with rosacea usually tend to develop subsequent CVD. Correct training for sufferers with rosacea to handle different modifiable danger elements of CVD together with rosacea is required.
Apoptosis and its therapeutic implications in neurodegenerative ailments
Neurodegenerative issues are characterised by progressive lack of explicit populations of neurons. Apoptosis has been implicated within the pathogenesis of neurodegenerative ailments, together with Parkinson illness, Alzheimer illness, Huntington illness, and amyotrophic lateral sclerosis.
On this evaluate, we give attention to the prevailing notions related to comprehending the apoptotic demise course of, together with the morphological options, mediators and regulators of mobile apoptosis. We additionally spotlight the proof of neuronal apoptotic demise in Parkinson illness, Alzheimer illness, Huntington illness, and amyotrophic lateral sclerosis.
Moreover, we current proof of potential therapeutic brokers that might modify the apoptotic pathway within the aforementioned neurodegenerative ailments and delay illness development. Lastly, we evaluate the medical trials that had been performed to judge the usage of anti-apoptotic medication within the therapy of the aforementioned neurodegenerative ailments, in an effort to spotlight the important want for early detection and intervention of neurodegenerative ailments in people.
Adjustments in Life Expectancy of Respiratory Illnesses from Attaining Day by day PM 2.5 Normal in China: A Nationwide Observational Research
Though publicity to air air pollution will increase the danger of untimely mortality and years of life misplaced (YLL), the results of every day air high quality enchancment to the life expectancy of respiratory ailments remained unclear. We utilized a generalized additive mannequin (GAM) to evaluate the associations between every day PM2.5 publicity and YLL from respiratory ailments in 96 Chinese language cities throughout 2013-2016.
We additional estimated the avoidable YLL, potential positive factors in life expectancy, and the attributable fraction by assuming every day PM2.5 focus lower to the air high quality requirements of China and World Well being Group. Regional and nationwide outcomes had been generated by random-effects meta-analysis.
A complete of 861,494 whole respiratory ailments and 586,962 continual obstructive pulmonary illness (COPD) induced demise from 96 Chinese language cities had been recorded throughout research interval. Every 10 μg/m3 enhance of PM2.5 in 3-day transferring common (lag02) was related to 0.16 (95% CI: 0.08, 0.24) years increment in life expectancy from whole respiratory ailments.
The best impact was noticed in Southwest area with 0.42 (95% CI: 0.22, 0.62) years enhance in life expectancy. By attaining the WHO’s Air High quality Tips, we estimated that a mean of 782.09 (95% CI: 438.29, 1125.89) YLLs brought on by whole respiratory demise in every metropolis may very well be averted, which corresponded to 1.15% (95% CI: 0.67%, 1.64%) of the general YLLs, and 0.12 (95% CI: 0.07, 0.17) years increment in life expectancy.
HPS4 Polyclonal Antibody |
|||
29756-100ul | SAB | 100ul | EUR 252 |
HPS4 Polyclonal Antibody |
|||
29756-50ul | SAB | 50ul | EUR 187 |
anti- HPS4 antibody |
|||
FNab04000 | FN Test | 100µg | EUR 585 |
Description: Antibody raised against HPS4 |
Anti-HPS4 antibody |
|||
STJ118610 | St John's Laboratory | 100 µl | EUR 277 |
HPS4 Blocking Peptide |
|||
DF12637-BP | Affbiotech | 1mg | EUR 195 |
Anti-HPS4 antibody |
|||
PAab04000 | Lifescience Market | 100 ug | EUR 412 |
Bradford reagent |
|||
BDE641 | Bio Basic | 100ml | EUR 61.01 |
Beaucage reagent |
|||
HY-100951 | MedChemExpress | 10mM/1mL | EUR 126 |
BOP reagent |
|||
5-02141 | CHI Scientific | 25g | Ask for price |
BOP reagent |
|||
5-02142 | CHI Scientific | 100g | Ask for price |
Bluing Reagent |
|||
BRT030 | ScyTek Laboratories | 30 ml | EUR 60 |
Bluing Reagent |
|||
BRT125 | ScyTek Laboratories | 125 ml | EUR 63 |
Bluing Reagent |
|||
BRT3800 | ScyTek Laboratories | 1 Gal. | EUR 184 |
Bluing Reagent |
|||
BRT500 | ScyTek Laboratories | 500 ml | EUR 76 |
Bluing Reagent |
|||
BRT999 | ScyTek Laboratories | 1000 ml | EUR 88 |
BOP reagent |
|||
A7015-100000 | ApexBio | 100 g | EUR 200 |
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis. |
BOP reagent |
|||
A7015-25000 | ApexBio | 25 g | EUR 113 |
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis. |
Traut's Reagent |
|||
2330-1000 | Biovision | EUR 349 |
Traut's Reagent |
|||
2330-500 | Biovision | EUR 207 |
MTS Reagent |
|||
2808-1000 | Biovision | EUR 990 |
MTS Reagent |
|||
2808-250 | Biovision | EUR 365 |
MTT Reagent |
|||
2809-1G | Biovision | EUR 180 |
MTT Reagent |
|||
2809-5G | Biovision | EUR 544 |
Chymase reagent |
|||
30C-CP1129 | Fitzgerald | 5 units | EUR 2185 |
Description: Purified native Human Chymase reagent |
Mouse HPS4 shRNA Plasmid |
|||
20-abx980430 | Abbexa |
|
|
Human HPS4 shRNA Plasmid |
|||
20-abx963853 | Abbexa |
|
|
HPS4 Polyclonal Conjugated Antibody |
|||
C29756 | SAB | 100ul | EUR 397 |
Mouse Hps4 ELISA KIT |
|||
ELI-38712m | Lifescience Market | 96 Tests | EUR 865 |
HPS4 ELISA KIT|Human |
|||
EF010213 | Lifescience Market | 96 Tests | EUR 689 |
HPS4 Recombinant Protein (Human) |
|||
RP063417 | ABM | 100 ug | Ask for price |
HPS4 Recombinant Protein (Rat) |
|||
RP205034 | ABM | 100 ug | Ask for price |
HPS4 Recombinant Protein (Mouse) |
|||
RP142325 | ABM | 100 ug | Ask for price |
LP4K Transfection Reagent |
|||
LP4K | GenTarget | 1.0 ml / vial | EUR 304 |
Description: Lipid based transfection reagent for large plasmid and multiple plasmid transfection in both adhesive and suspenstion cell types. |
Tri-RNA Reagent |
|||
FATRR-001 | Favorgen | 100ml | EUR 236 |
Tri-RNA Reagent |
|||
FATRR-002 | Favorgen | 50ml | EUR 176 |
Tri-RNA Reagent |
|||
FATRR-003 | Favorgen | 450ml | EUR 645 |
DTT (Cleland's reagent) |
|||
DB0058 | Bio Basic | 5g | EUR 84.8 |
DTNB (Ellman's Reagent) |
|||
DB0113 | Bio Basic | 5g | EUR 97.85 |
n-Heptane Reagent |
|||
HC5400 | Bio Basic | 1L | EUR 79 |
PhosphoBlocker Blocking Reagent |
|||
AKR-104 | Cell Biolabs | 4L | EUR 711 |
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins. |
PhosphoBlocker Blocking Reagent |
|||
AKR-103 | Cell Biolabs | 1L | EUR 328 |
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins. |
Ethyl acetate Reagent |
|||
EC4600 | Bio Basic | 1L | EUR 79 |
EL Transfection Reagent |
|||
20-abx098880 | Abbexa |
|
|
Mycoplasma Prevention Reagent |
|||
20-abx098886 | Abbexa |
|
|
Convoy? Transfection Reagent |
|||
1110-1ml | ACTGene | EUR 341 |
FcR blocking Reagent |
|||
20-abx290024 | Abbexa |
|
|
Detection Reagent A |
|||
abx296004-120ul | Abbexa | 120 ul | EUR 321 |
Mycoplasma Prevention Reagent |
|||
20-abx298005 | Abbexa |
|
|
Girard's reagent T |
|||
20-abx184099 | Abbexa |
|
|
TissueDigest Reagent, 20X |
|||
T101 | Insitus Biotechnologies | 10ml | EUR 210 |
HighGene transfection reagent |
|||
RM09014 | Abclonal | 1000μl | EUR 270 |
Griess Reagent Kit |
|||
30100 | Biotium | 1KIT | EUR 149 |
Description: Minimum order quantity: 1 unit of 1KIT |
Biolipidure-1002-Reagent |
|||
Biolipidure-1002-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-1002-Reagent is a synthetic amphoteric polymer that can be substituted for BSA in tubidimetric immunoassays. Biolipidure-1002 is an excellent blocker and also enhances assay sensitivity. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-103-Reagent |
|||
Biolipidure-103-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-103-Reagent |
|||
Biolipidure-103-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-1201-Reagent |
|||
Biolipidure-1201-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-1201 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-1201-Reagent |
|||
Biolipidure-1201-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-1201 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-1301-Reagent |
|||
Biolipidure-1301-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-1301 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-1301-Reagent |
|||
Biolipidure-1301-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-1301 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-203-Reagent |
|||
Biolipidure-203-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-203 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-203 has been shown to enhance signal strength by improving signal-to-noise in ELISAs, EIAs, and related immunoassays. It also functions as an effective blocker and stabilizer in these assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-203-Reagent |
|||
Biolipidure-203-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-203 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-203 has been shown to enhance signal strength by improving signal-to-noise in ELISAs, EIAs, and related immunoassays. It also functions as an effective blocker and stabilizer in these assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-206-Reagent |
|||
Biolipidure-206-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-206 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-206 enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-206-Reagent |
|||
Biolipidure-206-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-206 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-206 enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-405-Reagent |
|||
Biolipidure-405-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-405 Reagent is a synthetic anionic polymer that can be used to enhance immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-405-Reagent |
|||
Biolipidure-405-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-405 Reagent is a synthetic anionic polymer that can be used to enhance immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-502-Reagent |
|||
Biolipidure-502-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-502 Reagent is a synthetic cationic polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-502-Reagent |
|||
Biolipidure-502-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-502 Reagent is a synthetic cationic polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-702-Reagent |
|||
Biolipidure-702-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-702 Reagent is a synthetic amphoteric polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-702-Reagent |
|||
Biolipidure-702-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-702 Reagent is a synthetic amphoteric polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-802-Reagent |
|||
Biolipidure-802-10 | Biolipidure | 10mL | EUR 196 |
Description: The Biolipidure-802 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-802 generally enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, Rapid-test, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Biolipidure-802-Reagent |
|||
Biolipidure-802-100 | Biolipidure | 100mL | EUR 1223 |
Description: The Biolipidure-802 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-802 generally enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, Rapid-test, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
Alcohol, Reagent (70%) |
|||
EAS500 | ScyTek Laboratories | 500 ml | EUR 79 |
Alcohol, Reagent (70%) |
|||
EAS999 | ScyTek Laboratories | 1000 ml | EUR 101 |
Biolipidure-1002-Reagent |
|||
Biolipidure-1002-10 | Cusabio | 10mL | EUR 196 |
Description: The Biolipidure-1002-Reagent is a synthetic amphoteric polymer that can be substituted for BSA in tubidimetric immunoassays. Biolipidure-1002 is an excellent blocker and also enhances assay sensitivity. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
BCA Reagent, 16ML |
|||
C144-16ML | Arbor Assays | 16ML | EUR 163 |
Dissociation Reagent, 1ML |
|||
X017-1ML | Arbor Assays | 1ML | EUR 109 |
Dissociation Reagent, 25ML |
|||
X017-25ML | Arbor Assays | 25ML | EUR 258 |
Dissociation Reagent, 5ML |
|||
X017-5ML | Arbor Assays | 5ML | EUR 122 |
Dissociation Reagent, 1ML |
|||
X058-1ML | Arbor Assays | 1ML | EUR 73 |
Dissociation Reagent, 5ML |
|||
X058-5ML | Arbor Assays | 5ML | EUR 109 |
PureFection Transfection Reagent |
|||
LV750A-1 | SBI | 1 ml | EUR 359 |
Bradford Dye Reagent |
|||
0209R | AthenaES | 100 ml | EUR 131 |
BODIPY-Acetylene Reagent |
|||
2594-1 | Biovision | EUR 207 |
BODIPY-Acetylene Reagent |
|||
2594-5 | Biovision | EUR 675 |
ExFect2000 Transfection Reagent |
|||
T202-01 | Vazyme | 0.5 ml | EUR 227 |
ExFect2000 Transfection Reagent |
|||
T202-02 | Vazyme | 1 ml | EUR 316 |
ExFect2000 Transfection Reagent |
|||
T202-03 | Vazyme | 5 ml | EUR 1052 |
Biotin reagent (HRP) |
|||
65C-CE0202 | Fitzgerald | 5 mg | EUR 244 |
Description: HRP conjugated biotin labelling reagent |
HAMA blocking reagent |
|||
85R-1001 | Fitzgerald | 1 gram | EUR 1974 |
Description: HAMA Blocking Reagent for use in immunoassays such as ELISA |
HAMA blocking reagent |
|||
85R-1001P | Fitzgerald | 1 gram | EUR 2190 |
Description: HAMA Blocking Reagent for use in immunoassays such as ELISA |
HAMA blocking reagent |
|||
85R-1003 | Fitzgerald | 1 gram | EUR 1974 |
Description: HAMA Blocking Reagent for use in immunoassays such as Rapid Tests |
HAMA blocking reagent |
|||
85R-1014 | Fitzgerald | 50 mg | EUR 192 |
Description: HAMA blocking reagent for use in assays specific for clinical false positive samples |
×
The outcomes of COPD had been typically in line with whole respiratory ailments. Our findings point out that discount in every day PM2.5 concentrations would possibly result in longer life expectancy from respiratory demise.
Tags: 96 well plate cell culture anti rabbit igg anti rfp best automated cell counter biotin conjugated antibody biotinylated secondary antibody bovine serum albumin caspase 3 stain coomassie blue protein assay ctip antibody cytokine arrays cytokine elisa kit dna purification column fluorescent western blot foetal bovine serum cell culture hbss media heat inactivating fbs hsc70 antibody lactate dehydrogenase antibody lentiviral expression system mgmt antibody mirus transfection reagent nod2 antibody pcr hot start phospho h2ax prox1 antibody rna pol ii antibody strep tag antibody synaptophysin immunohistochemistry vwf antibody western blot antibody western blot scanner